Edelweiss Financial Services advised Curatio Healthcare Private Limited on its sale to Torrent Pharmaceuticals Limited

Curatio Healthcare is one of the largest pureplay Indian dermatology company primarily focused on cosmetic dermatology with a portfolio of 50 brands. The company has attained leadership position in pediatric dermatology which contributes c.55% to its total revenue. The company’s portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst top 5 brands in their respective markets. Edelweiss Financial Services acted as the sell-side advisor to Curatio Healthcare Private Limited on its sale of 100% stake to Torrent Pharmaceuticals Limited, the largest deal in the Indian dermatology sector.

Torrent Pharma is a leading global pharmaceutical company with a revenue of c. US$ 1bn* and market cap of US$ 6.5bn. The company has a very strong presence in Indian pharma market – ranks 8th in overall market and amongst top 5 in its key therapy areas which are cardio vascular, gastrointestinal, central nervous system and vitamins, minerals and nutrients. Torrent Pharma has a presence across 40 countries and is ranked #1 among the Indian pharma companies in Brazil, Germany and Philippines.




Edelweiss Financial Services

Advised in the sale of

Curatio Healthcare Private Limited


Torrent Pharmaceuticals Limited


MidCap Alliance